EyeControl is a medical technology company revolutionizing ICU care with its AI-powered eye-tracking platform. Designed to empower mechanically ventilated patients, it enables effective communication, connects families and caregivers, and provides healthcare teams with actionable insights. By supporting implementation of evidence-based practices for optimizing critical care, EyeControl enhances patient safety, improves cognitive and mental health outcomes, and fosters meaningful connections.
The EyeControl device is FDA-listed, CE-marked, ISO-certified, and AMAR and MAKAT registered as a communication solution. It is federally reimbursed in Israel for inpatient settings and homecare.